⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

BDX

Becton, Dickinson and Company

Healthcare · Medical Instruments & Supplies

179.80USD

+1.7500 (+0.98%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Loading security description…
A first visit to a security takes a few seconds.

Becton, Dickinson and Company

Ticker BDX · NYSE
Healthcare »Research »
Classification Medical Instruments & Supplies

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

1)

Price Chart

GP »

Price

 

 

1M6MYTD1Y5Y
Close
Px/Chg 1D (USD)179.80 / +0.98%
52 Wk H (02/06/26)210.02
52 Wk L (06/22/26)140.71
YTD Change/%-14.97 / -7.7%
Mkt Cap (USD)49.0B
Shrs Out/Float272.4M / 271.7M
SI/% of Float9.4M / 3.9%
Days to Cover5.1
2)

Estimates

EE »
Next Report11/05/26
P/E31.11
Est P/E 09/202613.53
T12M EPS (USD)5.78
Est EPS13.29
Est PEG1.11
Analyst Target$195.67
3)

Dividend

DVD »
Ind Gross Yield2.4%
Ind Ann Dvd (USD)4.20
5Y Avg Yield1.7%
Cash 06/09/261.05
Payout Ratio72.5%
Ex-Dvd Date09/09/26
4)

Total Return

COMP »
1M+1.27%
3M+17.80%
6M+9.29%
1Y-6.51%
3Y-32.86%
5Y-31.16%
52W vs SPX+20.90% / +17.48%
Beta0.28
5)

Trading

HP »
Day Range176.55 - 182.10
Prev Close178.05
Volume1.5M
Avg Volume2.1M
50d Avg170.47
200d Avg159.94
Employees72,000

Dated 52-week rows are the highest and lowest CLOSE and the day each happened, which sits a little inside the intraday range a vendor quotes. Quotes are refreshed once a night — during a session the price above is the previous close.